CORT

CORCEPT THERAPEUTICS INC

CORT·218352102·US·Common Stock·Healthcare - Biotechnology-13D/G

CORT (CORCEPT THERAPEUTICS INC) is held by 189 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($1.1B), RENAISSANCE TECHNOLOGIES LLC ($457.5M), VANGUARD PORTFOLIO MANAGEMENT LLC ($438.6M). Net institutional sentiment: Mixed.

189
Holders
(13 Elite)
$5.4B
Total Value
61% (198)
Consensus
121 buying - 77 selling
13F: Insider & Congress: Updated regularly
CORT

Smart Money Verdict

View all
Loading verdict
Held by 189 funds
13 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 28, 2026 · Activists Aug 13, 2026 · Congress none

InsiderPKPark KimberlyTax 3K shAug 26, 2026
InsiderPKPark KimberlyExercise 30K shAug 26, 2026
InsiderPKPark KimberlySell $3.3MAug 26, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
12.4M(+2.3%)$1.1B0.0%+134.33%
33
Decreased
5.3M(-7.4%)$457.5M0.6%+693.21%
0
Increased
5M(+4.7%)$438.6M0.0%+182.67%
33
Increased
4.2M(+2.3%)$362.8M0.0%+189.55%
32
Increased
3.3M(+4.6%)$290.2M0.0%+101.55%
32
Increased
3.3M(+2.5%)$285.2M0.0%+250.18%
32
Increased
2.6M(+535.8%)$224.6M0.1%+40.92%
49
Decreased
2.5M(-6.7%)$220.2M0.0%+296.61%
0
Decreased
1.8M(-15.8%)$159.1M0.1%+197.63%
0
Increased
1.4M(+1.0%)$119.8M0.0%+128.79%
30
Decreased
1.3M(-15.1%)$114.7M0.0%+377.88%
0
Increased
1.2M(+3.4%)$100.7M0.0%+223.32%
31
Increased
1.1M(+11.7%)$98.9M0.0%+139.34%
33
Decreased
883,001(-25.3%)$76.8M0.0%+211.97%
0
Increased
797,119(+8.9%)$69.3M0.1%+201.89%
32
Increased
753,796(+17.2%)$65.5M0.0%+313.75%
34
New
710,106$61.7M0.2%+37.78%
49
New
695,532$60.5M0.2%+37.78%
49
Increased
614,078(+4.0%)$53.4M0.0%+184.46%
31
Decreased
610,078(-35.5%)$53M0.0%+200.18%
0

Showing 1-20 of 202

1 / 11
CORTCORTCORCEPT THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used